Home > Brand & Businesses Brands & Businesses Dr.Perox is engaged in the following global business through constant dedication and effort: Medical and dental hygiene, General life, Agriculture and livestock, Global medical digital platform. |
Anti-Virus Disinfectant
Here's Dr. Perox's solution to prevent life-threatening pathogens, including COVID-19, and to reduce odors that create discomfort in dentistry and hospitals.
Learn more > |
Water Purification
Reducing odors due to moss and contaminants in various sewage treatment plants is essential for improving quality of life.
Learn more > |
Farm and Livestock
Prevention of insect infestation of crops that have been cherished for a year is very important for productivity. Also, hygiene at the wedding is becoming more important.
Learn more > |
Digital Distribution
Dr. Perox is dreaming of globalization through the digital distribution of various medical devices and dental materials.
Learn more > |
Latest Press Release
Decontamination and Reuse of Filtering Facepiece Respirators
While disposable filtering facepiece respirators (FFRs), like N95s, are not approved for routine decontamination as conventional standards of care, FFR decontamination and reuse may be needed during times of shortage to ensure continued availability. Based on the limited research available, as of April 2020, ultraviolet germicidal irradiation, vaporous hydrogen peroxide, and moist heat have shown the most promise as potential methods to decontaminate FFRs. This webpage summarizes research about decontamination of FFRs before reuse. Whether and how a facility decides to implement specific crisis strategies is at the discretion of its administrators and should be based on present and projected risk mitigation needs and local, regional, and national availability of N95s.
Before using any decontamination method, it should be evaluated for its ability to retain 1) filtration performance, 2) fit characteristics achieved prior to decontamination, and 3) safety of the FFR for the wearer (e.g. by inactivating SARS-CoV2).
See all Press Releases |